r.cabrera
Submits third-party assay reports on material purchased directly. Based in Rijeka.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.43%
n=9
Suppliers covered
8
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041861 | TB-500 | GSP | GSP-2511-Y4058 | Kestrel | 2026-Q2 | 99.60 | 5.65 | — | Buyer-sourced | 0 | PASS |
| AX-2025-020478 | KPV | KP | KP-2509-N5703 | PeptideMeter | 2025-Q4 | 99.25 | 2.32 | — | Buyer-sourced | 0 | FAIL |
| AX-2025-018588 | Semaglutide | QYB | QYB-2505-U5049 | Medutest | 2025-Q3 | 99.42 | 3.86 | 91.5 | Buyer-sourced | 1 | FAIL |
| AX-2025-020694 | Sermorelin | SGN | SGN-2502-Y8340 | PeptideMeter | 2025-Q3 | 98.71 | 5.14 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018545 | Ipamorelin | QYB | QYB-2408-A4637 | PeptideMeter | 2025-Q1 | 99.67 | 4.54 | — | Buyer-sourced | 0 | PASS |
| AX-2025-019868 | Retatrutide | HJ | HJ-2411-M5834 | Janoshik | 2024-Q4 | 98.29 | 6.38 | 93.1 | Buyer-sourced | 0 | PASS |
| AX-2024-004890 | Ipamorelin | ERP | ERP-2408-G9396 | Nordanalyt | 2024-Q3 | 99.68 | 4.79 | 94.7 | Buyer-sourced | 0 | PASS |
| AX-2024-004600 | Enclomiphene citrate | TFC | TFC-2404-J9626 | Janoshik | 2024-Q3 | 99.58 | 3.92 | — | Buyer-sourced | 0 | FAIL |
| AX-2024-004736 | TB-500 | Homopeptide | HOMO-2308-R3867 | Janoshik | 2024-Q1 | 99.43 | 2.99 | 106.9 | Buyer-sourced | 0 | PASS |